News and Trends 10 Jan 2019 This Retinal Implant Lets Visually-Impaired Patients See Patterns …shown no serious adverse events in any of the patients until now. A larger European pivotal study in around 50 patients is the next step for Pixium. By 2022, the… January 10, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 8 Sep 2022 OncoBone signs deals with three partners to work on bone metastases OncoBone Ventures has signed cooperation framework agreements with three partners. The company is a U.K. start up biotech looking to develop novel therapies for cancer patients with currently incurable bone… September 8, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 16 Sep 2022 Regeneron and Sanofi announce published trial results in children with dermatitis …profile in patients 6 years and older with atopic dermatitis. Adverse events that were more commonly observed with Dupixent – at 5% or less included conjunctivitis, herpes viral infections, molluscum… September 16, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 22 Mar 2017 Swedish Oncology Biotech Teams up with World Leading Cancer Center The Swedish biotech Aprea Therapeutics has entered a new collaboration with the Memorial Sloan Kettering Cancer Center to study the effects of its lead APR-246. Based in Stockholm, Aprea therapeutics… March 22, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Jun 2019 The Top 20 Industrial Biotechnology Companies in Europe Europe’s industrial biotechnology sector is driving a massive change from petrochemical processes to more sustainable alternatives. Here are the top industrial biotechnology companies in Europe making every industry greener. Industrial… June 19, 2019 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Nov 2022 Beckley Psytech completes treatment resistant depression and alcohol use disorder study Beckley Psytech, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic medicines, has completed its phase I clinical study of BPL-003, a synthetic… November 15, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jun 2020 Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B British biotech Evox Therapeutics has signed a collaboration deal worth up to €1.1B with US big pharma Eli Lilly to develop RNA drugs that are delivered in exosomes to the… June 11, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 31 Oct 2016 UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug …improvement in physical function of patient joints. There is a strong competition for antibody research into chronic auto-immune diseases such as Rheumatoid. A few Biotech giants are extra anxious to… October 31, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jun 2022 NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders …NRG and funded by Parkinson’s Virtual Biotech, the drug development arm of Parkinson’s UK, has led to the identification of small molecule lead series, which inhibit the mitochondrial inner membrane,… June 30, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Opinion 11 Jul 2022 Precision medicine: the next big leap for metabolic disorders …metabolic disorders, different therapeutic strategies are also needed for each patient endotype. Precision medicine prevents the waste of healthcare resources on treating patients with sub-optimal medications, which can increase their… July 11, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 1 Dec 2017 The Door Opens for Dutch Brain Surgery Device to Enter the Clinic …city of Groningen. It will support the clinical testing of its dura sealant patch, which prevents cerebrospinal fluid leakage, one of the most common complications of brain surgery. On the… December 1, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 27 Feb 2018 DBV Technologies’ Milk Allergy Patch Helps Kids in a Phase II Trial …to cow milk for 12 months. Boosted by these results, the biotech will begin looking at the optimal dosing and patient population for future studies. The company, whose market cap… February 27, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email